Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion — Stella

Home/Lactation Suppressed/Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion

View on ClinicalTrials.gov

Recruiting

Back to Lactation Suppressed trials

Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Northwestern Medical Center, Chicago, Illinois

Key details

Phase

Post-approval study

Sponsor

Northwestern University

Enrollment target

~200 participants

Started

December 2023

Primary completion

June 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 50 Years

Sex

Female only

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.